James J. Collins

Business address
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA, 02139
Top holdings (ownership)
FULC, ORIA, and SNTI
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
James J. Collins has filed 15 SEC EDGAR filings since 17 Jul 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 27 Jun 2025 25 Jun 2025 001-40440
4 Open Document Open Filing FORM 4 11 Mar 2025 07 Mar 2025 001-40440
4 Open Document Open Filing FORM 4 12 Jul 2024 10 Jul 2024 001-40440
4 Open Document Open Filing 4 18 Jun 2024 17 Jun 2024 001-38978
4 Open Document Open Filing 4 29 Jun 2023 27 Jun 2023 001-38978
4 Open Document Open Filing FORM 4 21 Jun 2023 16 Jun 2023 001-40440
4 Open Document Open Filing 18 May 2023 17 May 2023 001-40410
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jul 2022 13 Jul 2022 001-40440
4 Open Document Open Filing FORM 4 SUBMISSION 29 Jun 2022 27 Jun 2022 001-38978
3 Open Document Open Filing FORM 3 SUBMISSION 15 Jun 2022 08 Jun 2022 001-40440
4 Open Document Open Filing FORM 4 SUBMISSION 11 Jun 2021 09 Jun 2021 001-38978
3 Open Document Open Filing 12 May 2021 12 May 2021 001-40410
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jun 2020 11 Jun 2020 001-38978
4 Open Document Open Filing 4 18 Jul 2019 18 Jul 2019 001-38978
3 Open Document Open Filing 3 17 Jul 2019 17 Jul 2019 001-38978